Safety and Efficacy of the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with WaldenstrC6m Macroglobulinemia from a Phase 2 Trial
暂无分享,去创建一个
W. Novotny | Weili Zhao | Jie Jin | Jianfeng Zhou | L. Qiu | G. An | Jianyong Li | C. Du | Li-ping Xie | Dao-bin Zhou | L. Zhong | Lingzhi Yan | K. Zhou | Haiyi Guo | Jane E. Huang | Jin-rong Zhong